Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Stevanato Group SpA STVN

Technology Scientific & Technical Instruments
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug... see more

Recent & Breaking News (NYSE:STVN)

Stevanato Group to Report First Quarter 2022 Financial Results on May 10, 2022

Business Wire April 27, 2022

Stevanato Group Files Amendment No.1 to Its 2021 Annual Report on Form 20‑F/A

Business Wire April 5, 2022

Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Business Wire March 17, 2022

Stevanato Group to Create Manufacturing Hub in China

Business Wire March 10, 2022

Stevanato Group Reports Record 2021 Revenue of €843.9 million

Business Wire March 8, 2022

Stevanato Group Announces Agreement With BARDA for the Expansion of Vial Production to Create Industrial Base Capabilities for National Defense

Business Wire March 1, 2022

Stevanato Group to Report Fourth Quarter Financial Results on March 8, 2022

Business Wire February 18, 2022

Stevanato Group Appoints Riccardo Butta as President, Americas

Business Wire February 2, 2022

Stevanato Group Extends Pen Injector Technology Licensing Agreement With Haselmeier

Business Wire January 26, 2022

Stevanato Group Announces Expansion of Corporate Headquarters

Business Wire November 17, 2021

Stevanato Group Reports Strong Third Quarter 2021 Revenue and Financial Results and Updates Full Year 2021 Guidance

Business Wire November 9, 2021

Stevanato Group to Report Third Quarter Financial Results on November 9

Business Wire October 27, 2021

Stevanato Group Wins Pharma Innovation Award For AI-ready Vision Robot Unit (VRU)

Business Wire October 19, 2021

Stevanato Group Initiates Construction on New U.S. Facility

Business Wire October 4, 2021

Stevanato Group Announces Second Quarter 2021 Financial Results

Business Wire August 19, 2021

Stevanato Group Celebrates Initial Public Offering and First Day of Public Trading on New York Stock Exchange (NYSE)

Business Wire July 16, 2021

Stevanato Group Announces Pricing of Initial Public Offering

Business Wire July 15, 2021